Argentina, Mexico to Produce Oxford Vaccine for Latin America; Brazil Has Own Agreement

The agreement will allow the region to be supplied with up to 250 million doses of the coronavirus vaccine in the first half of next year, should the tests prove successful.

RIO DE JANEIRO, BRAZIL - Argentina and Mexico are at the forefront of the fight against the coronavirus pandemic in Latin America. Argentine President Alberto Fernández announced on Wednesday in Buenos Aires that the two countries will produce up to 250 million doses of the experimental vaccine that Oxford University is developing together with the British laboratory AstraZeneca.

The doses will be ready during the first half of next year. Each dose will cost betweenUS$2 and US$4, a "cost" price enabled by an agreement with the Slim Foundation for the development of the regional project.

The vaccine is . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?